EFFICACY AND SAFETY OF ETELCALCETIDE IN HEMODIALYSIS PATIENTS WITH SEVERE SECONDARY HYPERPARATHYROIDISM

被引：0
|
作者：
Massimetti, Carlo [1 ]
Borzacchi, Silvia [1 ]
Feriozzi, Sandro [1 ]
机构：
[1] Osped Belcolle, Viterbo, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP621
引用
收藏
页码：565 / 565
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism
    Monciino, Paola
    Magagnoli, Lorenza
    Fasulo, Eliana
    Frittoli, Michela
    Leotta, Chiara
    Pham, Hoang Nhat
    Stucchi, Andrea
    Ciceri, Paola
    Galassi, Andrea
    Cozzolino, Mario
    KIDNEY AND DIALYSIS, 2022, 2 (03): : 482 - 494
  • [2] LONG-TERM EFFICACY AND SAFETY OF ETELCALCETIDE IN HEMODIALYSIS PATIENTS WITH SEVERE SECONDARY HYPERPARATHYROIDISM
    Massimetti, Carlo
    Micarelli, David
    Feriozzi, Sandro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1717 - 1717
  • [3] EFFICACY AND SAFETY OF ETELCALCETIDE IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM INADEQUATELY CONTROLLED WITH CINACALCET
    Takahashi, Hiroo
    Komaba, Hirotaka
    Takahashi, Ryo
    Takahashi, Yuichiro
    Fukagawa, Masafumi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [4] One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
    Bushinsky, David A.
    Chertow, Glenn M.
    Cheng, Sunfa
    Deng, Hongjie
    Kopyt, Nelson
    Martin, Kevin J.
    Rastogi, Anjay
    Urena-Torres, Pablo
    Vervloet, Marc
    Block, Geoffrey A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (10) : 1769 - 1778
  • [5] An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism
    Block, Geoffrey A.
    Chertow, Glenn M.
    Sullivan, John T.
    Deng, Hongjie
    Mather, Omar
    Tomlin, Holly
    Serenko, Michael
    PLOS ONE, 2019, 14 (03):
  • [6] Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in "Real Life"
    Russo, Domenico
    Tripepi, Rocco
    Malberti, Fabio
    Di Iorio, Biagio
    Scognamiglio, Bernadette
    Di Lullo, Luca
    Paduano, Immacolata Gaia
    Tripepi, Giovanni Luigi
    Panuccio, Vincenzo Antonio
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (07):
  • [7] EFFECTIVENESS AND SAFETY OF ETELCALCETIDE IN THE LONG TERM IN CLINICAL PRACTICE IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
    Diaz Campillejo, Rosa
    Calero Cendrero, Rosa Maria Ruiz
    Olivera Azevedo, Lilia
    Rodriguez Sabillon, Jorge Alberto
    Ruiz Jimenez, Belen
    Fernandez Solis, Maria Antonia
    Galan Gonzalez, Maria Josefa
    Cancho Castellano, Barbara
    Hidalgo Barquero, Maria Victoria Martin
    Barroso-Hernandez, Sergio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1746 - 1746
  • [8] EXPERIENCES WITH INTRAVENOUS ETELCALCETIDE IN LONG-TERM HEMODIALYSIS PATIENTS WITH SEVERE SECONDARY HYPERPARATHYROIDISM
    Pernat, Andreja Marn
    Gubensek, Jakob
    Cede, Ana Zupunski
    Knap, Bojan
    Persic, Vanja
    Trampuz, Barbara Vajdic
    Ponikvar, Jadranka Buturovic
    Ponikvar, Rafael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [9] ONE YEAR EFFICACY AND SAFETY OF INTRAVENOUS (IV) ETELCALCETIDE (AMG 416) IN PATIENTS ON HEMODIALYSIS (HD) WITH SECONDARY HYPERPARATHYROIDISM (SHPT)
    Bushinsky, David A.
    Block, Geoffrey A.
    Cheng, Sunfa
    Deng, Hongjie
    Torres, Pablo Urena
    Vervloet, Matrc
    Chertow, Glenn M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 13 - 14
  • [10] CLINICAL IMPACTS OF ETELCALCETIDE IN PATIENTS RECEIVING HEMODIALYSIS WITH SECONDARY HYPERPARATHYROIDISM IN JAPAN
    Ito, Minoru
    Masakane, Ikuto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
12345